Medicinova (MNOV) Revenue (2012 - 2026)

Medicinova (MNOV) posted quarterly Revenue of $151739.0 for Q4 2025, up 23.05% quarter-over-quarter from $123319.0 in Q3 2025.

Medicinova (MNOV) Revenue (2012 - 2026) Analysis & Trends

Medicinova (MNOV) has reported Revenue for 5 consecutive years, with $151739.0 the latest figure, recorded in Q4 2025.

In Q4 2025, Revenue changed N/A year-over-year to $151739.0; the TTM figure through Dec 2025 stood at $409657.0 (changed N/A YoY), while the FY2025 annual figure was $409657.0, changed N/A from the prior year.
Revenue improved to $151739.0 in Q4 2025 per MNOV's latest filing, from $123319.0 in the prior quarter.
Across five years, Revenue topped out at $4.0 million in Q1 2021 and bottomed at $37500.0 in Q3 2021.
Historically, Revenue has averaged $907859.5 across 3 years, with a median of $143169.0 in 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Revenue (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	3.33 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	4.29 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	1.52 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	145.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	1.71 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	1.29 Bn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	1.06 Bn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	425.49 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	674.14 Mn
10	Medicinova	68.42 Mn	68.42 Mn	317,759.00	458,439.00

Download Data